APA (7th ed.) Citation

NR, R., I, S., O, D., T, N., K, G., S, L., . . . JN, S. (2026). Levetiracetam prevents Aβ production through SV2a-dependent modulation of APP processing in Alzheimer's disease models. Science translational medicine, 18(836), eadp3984. https://doi.org/10.1126/scitranslmed.adp3984

Chicago Style (17th ed.) Citation

NR, Rao, et al. "Levetiracetam Prevents Aβ Production Through SV2a-dependent Modulation of APP Processing in Alzheimer's Disease Models." Science Translational Medicine 18, no. 836 (2026): eadp3984. https://doi.org/10.1126/scitranslmed.adp3984.

MLA (9th ed.) Citation

NR, Rao, et al. "Levetiracetam Prevents Aβ Production Through SV2a-dependent Modulation of APP Processing in Alzheimer's Disease Models." Science Translational Medicine, vol. 18, no. 836, 2026, p. eadp3984, https://doi.org/10.1126/scitranslmed.adp3984.